ClinicalTrials.Veeva

Menu

Examination of Biomechanical Characteristics of Linea Alba in Diastasis Recti Patients

S

South Valley University

Status

Not yet enrolling

Conditions

Separated Recti Abdominis

Treatments

Device: Ultrasonography
Device: The MyotonPRO Device

Study type

Observational

Funder types

Other

Identifiers

NCT06492603
Diastasis Recti

Details and patient eligibility

About

Diastasis recti is an increased distance between the rectus abdominis muscles at the midline caused by weakness in the anterior abdominal wall.

Full description

Most healthcare providers agree that in diastasis rectus abdominis there is a weakness, thinning, and widening of the linea alba and weakness of the associated abdominal musculature.

Ultrasonography is regarded as the most accurate method for measuring the IRD and its results are consistent with the data derived from palpation, calipers, and intraoperative measurements.

The MyotonPRO Device is used for the non-invasive measurement of Device is for the non-invasive measurement of biomechanical and viscoelastic properties of superficial soft biological tissues. Skeletal muscles or tendons can be measured at different regions, at full rest or in contraction.

This study aims to assess the biomechanical and viscoelastic properties of the Linea Alba in patients who are diagnosed with diastasis rectus abdominis by ultrasonography.

Enrollment

40 estimated patients

Sex

Female

Ages

18 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Postpartum Mothers who delivered by a cesarean section.
  • Postpartum Mothers with a BMI below 30 or a Waist-hip ratio below 1.
  • Postpartum Mothers above 18 years old and those below 35 years old.

Exclusion criteria

  • Postpartum Mothers who delivered by a vaginal delivery.
  • Postpartum Mothers who had hernias in the abdominal region or laparotomy.
  • Postpartum Mothers with a BMI over 30 or a Waist-hip ratio over 1.
  • Postpartum Mothers below 18 years old and those above 35 years old.

Trial design

40 participants in 2 patient groups

20 Women in the Postpartum Diastasis Recti Group
Treatment:
Device: The MyotonPRO Device
Device: Ultrasonography
20 Women in the Control Group (Postpartum Without Diastasis Recti)
Treatment:
Device: The MyotonPRO Device
Device: Ultrasonography

Trial contacts and locations

0

Loading...

Central trial contact

Mohamed G Shehata, Lecturer

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems